PROVIDER PROFILE · NPI 1326084534

Ravi ViswanathanMD

PRACTICEUNIVERSITY OF WISCONSIN MEDICAL FOUNDATION, INCSee all providers at this practice →

Allergy/ ImmunologyMadison, WII

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

428

Unique beneficiaries

—

Total services

789

Distinct HCPCS

Medicare payment

$23K

Peer benchmark

Total Medicare services vs. 59 Allergy/ Immunology providers in WI — below median (cohort median 1,511).

PRESCRIBING · PART D · 2024

Total Rx claims

1,946

Beneficiaries

—

Total drug cost

$1.3M

Distinct drugs

Brand share

63.2%

Top prescribed drugs

Montelukast Sodium247 claims

Fluticasone Propionate154 claims

Mometasone/Formoterol139 claims

Fluticasone Propionate108 claims

Albuterol Sulfate105 claims

QUALITY · MIPS · 2024

Final MIPS score

83.3

Quality

87.8

Cost

75.8

Improvement activities

40.0

Promoting interop.

77.0

Payment adjustment

0.35%

Group

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$4K

Payment records

By payment type

Consulting Fee$4K

Food and Beverage$19

FACILITY AFFILIATIONS

Hospital & Facility Affiliations (2)

CCN 520089

Hospital

CCN 520098

Hospital

REFERRAL NETWORK

Where Ravi Viswanathan's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 0 inbound referrers · 1 outbound destinations.

Receives referrals from

Inbound — who sends patients here

No inbound pairs above the suppression threshold.

Refers patients to

Outbound — where patients go next

Physician	Patients	Visits
UNIVERSITY OF WISCONSIN HOSPITALS AND CLINICS AUTHORITY	175	1,640

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history